Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of nebivolol versus atenolol on cardiovascular measures and insulin sensitivity in hypertension
2005-001214-40Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) comparing Nebivolol with Atenolol (2 arms). Primary endpoint: Insulin sensitivity index difference. Started Aug 2007; status: completed.
02
Drugs
nebivololatenolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2005-001214-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001214-40.